albuquerque semaglutide Mount Sinai Doctors Weight Loss Center Overcoming Plateaus: Advancing Your Weight

doi: 10.1377/hlthaff.2024.01006

Semaglutide is a GLP-1 receptor agonist while tirzepatide activates both GIP and GLP-1 receptors, which can lead to larger average weight loss in some trials

doi:10.1210/en.2009-1272 Song Y, Zhou M, Cao Y, Qi J, Geng J, Liu X

3163 involves claims that Ozempic and other GLP-1 medications caused non-arteritic anterior ischemic optic neuropathy, or NAION, a serious optic nerve injury that can cause sudden and permanent vision loss

It sits in a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm and should help with comparison and decision support

[DOI] [PubMed] [Google Scholar] Rocca AS, Brubaker PL